可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 贾智博,田海,刘开宇,等. 基质金属蛋白酶组织抑制因子3基因转染血管平滑肌细胞移植对急性心肌梗死后早期心肌重塑的影响[J]. 中国修复重建外科杂志, 2007, 21(5):512-516.
[2] Nakamura A, Isoyama S, Watanabe T, et al. Heterogeneous smooth muscle cell population derived from small and larger arteries[J]. Microvasc Res, 1998, 55(1):14-28.
[3] 尹倪,陈胜喜,罗万俊,等. 冠状动脉前降支结扎法制作大鼠急性心肌梗死模型[J]. 中国医师杂志, 2006, 8(9):1193-1195.
[4] 周欣,李玉明. 心肌梗死后创伤修复与心室重塑[J]. 中华心血管病杂志, 2004, 32(4):375-377.
[5] Gelfand EV, Cannon CP. Myocardial infarction: contemporary management strategies[J]. J Intern Med, 2007, 262(1):59-77.
[6] Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point[J]. Circulation, 2005, 112(20):3174-3183.
[7] Yasuda T, Weisel RD, Kiani C, et al. Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction[J]. J Thorac Cardiovasc Surg, 2005, 129(4):904-911.
[8] Li RK, Jia ZQ, Weisel RD, et al. Smoothmuscle cell transplantation into myocardial scar tissue improves heart function[J]. J Mol Cell Cardiol, 1999, 31(3):513-522.
[9] Cohn JN, Ferrari R, Sharpe N, et al. Cardiac remodeling concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling[J]. J Am Coll Cardiol, 2000, 35(3):569-582.
[10]朱勇,李玉明. 基质金属蛋白酶及其抑制剂与心肌梗死后心室重塑[J]. 心血管病学进展, 2004, 25(Z1):105-108.
[11]郝玉明,朱文玲. 心肌梗死后的心室重构[J]. 中华心血管病杂志, 2005, 33(2):196-197.
[12]Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior[J]. Annu Rev Cell Dev Biol, 2001, 17(4):463-516.
[13]Fedak PW, Altamentova SM, Weisel RD, et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3[J]. Am J Physiol Heart Circ Physiol, 2003, 284(2):H626-H634.
[14]Fedak PW, Smookler DS, Kassiri Z, et al. TIMP-3 deficiency leads to dilated cardiomyopathy[J]. Circulation, 2004, 110(16):2401-2409.